Med ePad, a Liverpool Science Park, UK-based mobile health company, has raised £125k in third funding.
This follow-on investment was made by The North West Fund for Biomedical, managed by SPARK Impact, which has now committed £250k in the business.
Med ePad plans to use this new tranche to employ additional staff (http://www.medepad.com/index.php/vacancies/) and expand its project development pipeline.
Led by chief technical officer and founder Rob Connell, the company provides interactive devices (7-inch tablets) and apps (created in conjunction with NHS healthcare professionals) designed to enable patients to manage their self-care and address problematic areas such as missed appointments rates, post operative care and the management of long term condition sufferers.
FinSMEs
01/12/2012